83 FR 46960 - Advisory Council on Alzheimer's Research, Care, and Services; Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 180 (September 17, 2018)

Page Range		46960-46961
FR Document		2018-20110

This notice announces the public meeting of the Advisory Council on Alzheimer's Research, Care, and Services (Advisory Council). The Advisory Council on Alzheimer's Research, Care, and Services provides advice on how to prevent or reduce the burden of Alzheimer's disease and related dementias on people with the disease and their caregivers. During the October meeting, the Long-Term Services and Supports Subcommittee will be taking charge of the theme. The topics covered will include: (1) The experience of people with dementia who have special needs due to issues like diversity, geography, and concurrent disorders; (2) How clinical care can be better integrated with community-based supports and services; and (3) Evidence-based behavioral approaches that mitigate the impact of behavioral symptoms of dementia. The meeting will also include updates on work from the previous meetings and federal workgroup updates.

Federal Register, Volume 83 Issue 180 (Monday, September 17, 2018)

[Federal Register Volume 83, Number 180 (Monday, September 17, 2018)]
[Notices]
[Pages 46960-46961]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-20110]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council on Alzheimer's Research, Care, and Services 
provides advice on how to prevent or reduce the burden of Alzheimer's 
disease and related dementias on people with the disease and their 
caregivers. During the October meeting, the Long-Term Services and 
Supports Subcommittee will be taking charge of the theme. The topics 
covered will include: (1) The experience of people with dementia who 
have special needs due to issues like diversity, geography, and 
concurrent disorders; (2) How clinical care can be better integrated 
with community-based supports and services; and (3) Evidence-based 
behavioral approaches that mitigate the impact of behavioral symptoms 
of dementia. The meeting will also include

[[Page 46961]]

updates on work from the previous meetings and federal workgroup 
updates.

DATES: The meeting will be held on October 19, 2018 from 9 a.m. to 5 
p.m. EDT.

ADDRESSES: The meeting will be held in Room 800 in the Hubert H. 
Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201.
    Comments: Time is allocated in the afternoon on the agenda to hear 
public comments. The time for oral comments will be limited to two (2) 
minutes per individual. In lieu of oral comments, formal written 
comments may be submitted for the record to Rohini Khillan, OASPE, 200 
Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may 
also be sent to [email protected]. Those submitting written comments should 
identify themselves and any relevant organizational affiliations.

FOR FURTHER INFORMATION CONTACT: Rohini Khillan (202) 690-5932, 
[email protected]. Note: Seating may be limited. Those wishing to 
attend the meeting must send an email to [email protected] and put ``October 
19 Meeting Attendance'' in the Subject line by Wednesday, October 10, 
so that their names may be put on a list of expected attendees and 
forwarded to the security officers at the Department of Health and 
Human Services. Any interested member of the public who is a non-U.S. 
citizen should include this information at the time of registration to 
ensure that the appropriate security procedure to gain entry to the 
building is carried out. Although the meeting is open to the public, 
procedures governing security and the entrance to Federal buildings may 
change without notice. If you wish to make a public comment, you must 
note that within your email.

SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting: During the October meeting, the Long-
Term Services and Supports Subcommittee will be taking charge of the 
theme. The topics covered will include: (1) The experience of people 
with dementia who have special needs due to issues like diversity, 
geography, and concurrent disorders; (2) How clinical care can be 
better integrated with community-based supports and services; and (3) 
Evidence-based behavioral approaches that mitigate the impact of 
behavioral symptoms of dementia. The meeting will also include updates 
on work from the previous meetings and federal workgroup updates.
    Procedure and Agenda: This meeting is open to the public. Please 
allow 30 minutes to go through security and walk to the meeting room. 
The meeting will also be webcast at www.hhs.gov/live.

    Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of 
Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets 
forth standards for the formation and use of advisory committees.

    Dated: September 10, 2018.
Brenda Destro,
Deputy Assistant Secretary for Planning and Evaluation, Office of Human 
Services Policy.
[FR Doc. 2018-20110 Filed 9-14-18; 8:45 am]
 BILLING CODE 4150-05-P

46960 Federal Register / Vol. 83, No. 180 / Monday, September 17, 2018 / Notices

Blood Safety.’’ The purpose of the II. Topics for Discussion at the Public reduction-technologies-for-blood-safety-
public workshop is to foster the Workshop public-workshop-tickets-4464956605. A
development and implementation of The first day of the workshop will link to the live webcast will be provided
pathogen reduction technologies for include presentations and panel upon registration.
blood components intended for If you have never attended a Connect
discussions on the following topics: (1)
transfusion. The workshop will include Pro event before, test your connection at
Transfusion-transmitted infectious
presentations and panel discussions by https://collaboration.fda.gov/common/
agents and their impact on blood safety;
experts from academic institutions, help/en/support/meeting_test.htm. To
(2) status of pathogen reduction
industry, and government agencies. get a quick overview of the Connect Pro
technology for blood components
program, visit https://www.adobe.com/
DATES: The public workshop will be intended for transfusion, including
go/connectpro_overview. FDA has
held on November 29, 2018, from 8 a.m. challenges to implementation in the verified the website addresses in this
to 5 p.m., and on November 30, 2018, United States; and (3) the development document as of the date this document
of pathogen reduction technology for publishes in the Federal Register, but
from 9 a.m. to 1 p.m. See the
whole blood and red blood cells. websites are subject to change over time.
SUPPLEMENTARY INFORMATION section for
The second day of the workshop will Transcripts: Please be advised that as
registration date and information. include presentations and panel soon as a transcript of the public
ADDRESSES: The public workshop will discussions on the following topics: (1) workshop is available, it will be
be held at the FDA White Oak Campus, Emerging pathogen reduction accessible at https://www.regulations.
10903 New Hampshire Ave., Bldg. 31 technologies and alternative approaches gov. It may be viewed at the Dockets
Conference Center, the Great Room (Rm. to controlling risk; (2) potential funding Management Staff (HFA–305), Food and
1503, sections B and C), Silver Spring, opportunities for research; and (3) a Drug Administration, 5630 Fishers
MD 20993. Entrance for the public summary of all workshop sessions, Lane, Rm. 1061, Rockville, MD 20852. A
workshop participants (non-FDA panel discussions, and future directions. link to the transcript will also be
employees) is through Building 1, where III. Participating in the Public available on the internet at https://
routine security check procedures will Workshop www.fda.gov/BiologicsBloodVaccines/
be performed. For parking and security NewsEvents/WorkshopsMeetings
Registration: To register for the public
information, please refer to https:// Conferences/default.htm.
workshop, please visit the following
www.fda.gov/AboutFDA/Workingat Dated: September 11, 2018.
website: https://www.eventbrite.com/e/
FDA/BuildingsandFacilities/WhiteOak pathogen-reduction-technologies-for- Leslie Kux,
CampusInformation/ucm241740.htm. blood-safety-public-workshop-tickets- Associate Commissioner for Policy.
FOR FURTHER INFORMATION CONTACT: Loni 4464956605. Please provide complete [FR Doc. 2018–20090 Filed 9–14–18; 8:45 am]
Warren Henderson or Sherri Revell, contact information for each attendee, BILLING CODE 4164–01–P
Center for Biologics Evaluation and including name, title, affiliation,
Research, Food and Drug address, email, and telephone.
Administration, 10903 New Hampshire Registration is free and based on DEPARTMENT OF HEALTH AND
Ave., Silver Spring, MD 20993, 240– space availability, with priority given to HUMAN SERVICES
402–8010, email: CBERPublicEvents@ early registrants. Persons interested in
attending this public workshop must Advisory Council on Alzheimer’s
fda.hhs.gov (subject line: Pathogen Research, Care, and Services; Meeting
Reduction Technology and Blood register by November 8, 2018, midnight
Safety). Eastern Time. Early registration is AGENCY: Assistant Secretary for
recommended because seating is Planning and Evaluation, HHS.
SUPPLEMENTARY INFORMATION: limited; therefore, FDA may limit the ACTION: Notice of meeting.
number of participants from each
I. Background organization. If time and space permit, SUMMARY: This notice announces the
Pathogen reduction technology has onsite registration on the day of the public meeting of the Advisory Council
public workshop will be provided, on Alzheimer’s Research, Care, and
the potential to improve blood safety by
beginning at 7 a.m. Services (Advisory Council). The
reducing or eliminating infectious
If you need special accommodations, Advisory Council on Alzheimer’s
organisms, including bacteria, viruses,
due to a disability, please contact Loni Research, Care, and Services provides
and parasites, from blood components Warren Henderson or Sherri Revell no advice on how to prevent or reduce the
intended for transfusion. FDA granted later than November 19, 2018 (see FOR burden of Alzheimer’s disease and
approvals for use of a pathogen FURTHER INFORMATION CONTACT). Request related dementias on people with the
reduction technology platform in for sign language interpretation or disease and their caregivers. During the
manufacturing plasma and apheresis Computer Aided Realtime Translation October meeting, the Long-Term
platelets for transfusion. Ideally, (CART)/captioning should be made 2 Services and Supports Subcommittee
pathogen reduction technology should weeks in advance of the event, no later will be taking charge of the theme. The
also be available for whole blood and than November 15, 2018. A request for topics covered will include: (1) The
red blood cells. Implementation of safe either interpreting or captioning should experience of people with dementia
and effective pathogen reduction be sent directly to the FDA Interpreting who have special needs due to issues
technology may also permit alternative Services Staff email account: like diversity, geography, and
daltland on DSKBBV9HB2PROD with NOTICES

donor screening or donation testing interpreting.services@oc.fda.gov. concurrent disorders; (2) How clinical
strategies in the future. The purpose of Streaming Webcast of the Public care can be better integrated with
the public workshop is to foster the Workshop: This public workshop will community-based supports and
development and implementation of also be webcast. Individuals who wish services; and (3) Evidence-based
pathogen reduction technologies for all to view the webcast should register for behavioral approaches that mitigate the
blood components intended for the workshop at https:// impact of behavioral symptoms of
transfusion. www.eventbrite.com/e/pathogen- dementia. The meeting will also include

VerDate Sep<11>2014 17:47 Sep 14, 2018 Jkt 244001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\17SEN1.SGM 17SEN1

Federal Register / Vol. 83, No. 180 / Monday, September 17, 2018 / Notices 46961

updates on work from the previous meetings and federal workgroup Dated: September 11, 2018.
meetings and federal workgroup updates. Melanie J. Pantoja,
updates. Procedure and Agenda: This meeting Program Analyst, Office of Federal Advisory
is open to the public. Please allow 30 Committee Policy.
DATES: The meeting will be held on
minutes to go through security and walk [FR Doc. 2018–20111 Filed 9–14–18; 8:45 am]
October 19, 2018 from 9 a.m. to 5 p.m.
EDT. to the meeting room. The meeting will BILLING CODE 4140–01–P

ADDRESSES: The meeting will be held in also be webcast at www.hhs.gov/live.
Room 800 in the Hubert H. Humphrey Authority: 42 U.S.C. 11225; Section 2(e)(3) DEPARTMENT OF HEALTH AND
Building, 200 Independence Avenue of the National Alzheimer’s Project Act. The HUMAN SERVICES
SW, Washington, DC 20201. panel is governed by provisions of Public
Comments: Time is allocated in the Law 92–463, as amended (5 U.S.C. Appendix National Institutes of Health
afternoon on the agenda to hear public 2), which sets forth standards for the
comments. The time for oral comments formation and use of advisory committees. Center for Scientific Review; Notice of
will be limited to two (2) minutes per Closed Meetings
Dated: September 10, 2018.
individual. In lieu of oral comments, Pursuant to section 10(d) of the
Brenda Destro,
formal written comments may be Federal Advisory Committee Act, as
submitted for the record to Rohini Deputy Assistant Secretary for Planning and
Evaluation, Office of Human Services Policy. amended, notice is hereby given of the
Khillan, OASPE, 200 Independence following meetings.
Avenue SW, Room 424E, Washington, [FR Doc. 2018–20110 Filed 9–14–18; 8:45 am]
The meetings will be closed to the
DC 20201. Comments may also be sent BILLING CODE 4150–05–P
public in accordance with the
to napa@hhs.gov. Those submitting provisions set forth in sections
written comments should identify 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
themselves and any relevant DEPARTMENT OF HEALTH AND as amended. The grant applications and
organizational affiliations. HUMAN SERVICES the discussions could disclose
FOR FURTHER INFORMATION CONTACT: confidential trade secrets or commercial
National Institutes of Health
Rohini Khillan (202) 690–5932, property such as patentable material,
rohini.khillan@hhs.gov. Note: Seating National Institute on Aging; Notice of and personal information concerning
may be limited. Those wishing to attend Closed Meeting individuals associated with the grant
the meeting must send an email to applications, the disclosure of which
napa@hhs.gov and put ‘‘October 19 would constitute a clearly unwarranted
Pursuant to section 10(d) of the
Meeting Attendance’’ in the Subject line invasion of personal privacy.
Federal Advisory Committee Act, as
by Wednesday, October 10, so that their Name of Committee: Endocrinology,
names may be put on a list of expected amended, notice is hereby given of the
Metabolism, Nutrition and Reproductive
attendees and forwarded to the security following meeting.
Sciences Integrated Review Group;
officers at the Department of Health and The meeting will be closed to the Integrative Physiology of Obesity and
Human Services. Any interested public in accordance with the Diabetes Study Section.
member of the public who is a non-U.S. provisions set forth in sections Date: October 9–10, 2018.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Time: 8:00 a.m. to 5:00 p.m.
citizen should include this information Agenda: To review and evaluate grant
at the time of registration to ensure that as amended. The grant applications and applications.
the appropriate security procedure to the discussions could disclose Place: Wyndham Grand Chicago
gain entry to the building is carried out. confidential trade secrets or commercial Riverfront, 71 E Wacker Drive, Chicago, IL
Although the meeting is open to the property such as patentable material, 60601.
public, procedures governing security and personal information concerning Contact Person: Raul Rojas, Ph.D.,
and the entrance to Federal buildings individuals associated with the grant Scientific Review Officer, Center for
Scientific Review, National Institutes of
may change without notice. If you wish applications, the disclosure of which
Health, 6701 Rockledge Drive, Room 6185,
to make a public comment, you must would constitute a clearly unwarranted Bethesda, MD 20892, (301) 451–6319, rojasr@
note that within your email. invasion of personal privacy. mail.nih.gov.
SUPPLEMENTARY INFORMATION: Notice of Name of Committee: National Institute on Name of Committee: Center for Scientific
these meetings is given under the Aging Special Emphasis Panel; Next Review Special Emphasis Panel; Behavioral
Federal Advisory Committee Act (5 Generation of Basic Alzheimer’s Disease Genetics and Epidemiology.
U.S.C. App. 2, section 10(a)(1) and Researchers. Date: October 10, 2018.
(a)(2)). Topics of the Meeting: During Time: 8:30 a.m. to 6:00 p.m.
Date: October 17–18, 2018.
Agenda: To review and evaluate grant
the October meeting, the Long-Term Time: 1:00 p.m. to 4:00 p.m. applications.
Services and Supports Subcommittee Agenda: To review and evaluate grant Place: St. Gregory Hotel, 2033 M Street
will be taking charge of the theme. The applications. NW, Washington, DC 20036.
topics covered will include: (1) The Place: Hyatt Regency Bethesda, One Contact Person: Karen Nieves Lugo, Ph.D.,
experience of people with dementia Bethesda Metro Center, 7400 Wisconsin Scientific Review Officer, Center for
who have special needs due to issues Avenue, Bethesda, MD 20814. Scientific Review, National Institutes of
like diversity, geography, and Contact Person: Ramesh Vemuri, Ph.D., Health, Bethesda, MD 20892,
concurrent disorders; (2) How clinical Chief, Scientific Review Branch, Scientific karen.nieveslugo@nih.gov.
daltland on DSKBBV9HB2PROD with NOTICES

care can be better integrated with Review Branch, National Institute on Aging, Name of Committee: Oncology 2—
community-based supports and National Institutes of Health, 7201 Wisconsin Translational Clinical Integrated Review
Avenue, Suite 2C–212, Bethesda, MD 20892, Group; Radiation Therapeutics and Biology
services; and (3) Evidence-based Study Section.
behavioral approaches that mitigate the 301–402–7700, rv23r@nih.gov.
Date: October 11–12, 2018.
impact of behavioral symptoms of (Catalogue of Federal Domestic Assistance Time: 8:00 a.m. to 5:00 p.m.
dementia. The meeting will also include Program Nos. 93.866, Aging Research, Agenda: To review and evaluate grant
updates on work from the previous National Institutes of Health, HHS) applications.

VerDate Sep<11>2014 17:47 Sep 14, 2018 Jkt 244001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\17SEN1.SGM 17SEN1

Document Created: 2018-09-15 01:37:47
Document Modified: 2018-09-15 01:37:47

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of meeting.
Dates		The meeting will be held on October 19, 2018 from 9 a.m. to 5 p.m. EDT.
Contact		Rohini Khillan (202) 690-5932, [email protected] Note: Seating may be limited. Those wishing to attend the meeting must send an email to [email protected] and put ``October 19 Meeting Attendance'' in the Subject line by Wednesday, October 10, so that their names may be put on a list of expected attendees and forwarded to the security officers at the Department of Health and Human Services. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email.
FR Citation		83 FR 46960